CEACAM5 and colorectal cancer: Finally, the antitumor activity of two different doses (25 or 50 μg) of IMTXCEAαS and IMTXTRICEAαS was assayed in nude mice bearing CEA-positive human colorectal cancer xenografts (Fig. 7A).